The U.S. Department of Justice has urged a federal appeals court to maintain the nationwide ban on cannabis, defending Congress's broad authority to regulate the substance despite its legalization in many states.
In a brief filed last Thursday with the U.S. Court of Appeals for the First Circuit, government lawyers argued that the Controlled Substances Act (CSA) should be upheld, citing Supreme Court precedent that grants Congress the power to regulate marijuana under the Commerce Clause, reported Green Market Report.
The case, spearheaded by Massachusetts-based retailer Canna Provisions Inc. and supported by companies like Verano Holdings VRNOF, aims to overturn the federal marijuana ban.
The plaintiffs are aiming to revive a lawsuit that was dismissed in July. U.S. District Judge Mark Mastroianni ruled that lower courts must follow the Supreme Court's 2005 decision in Gonzales v. Raich, which upheld federal prohibition unless the Court itself overturned the ruling.
Read Also: The Court Case That Could Change The Cannabis Industry Forever And How It Affects Rescheduling
- Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you’re serious about the business, you can’t afford to miss out.
Famous Attorney Leads The Case
The plaintiffs, represented by attorney David Boies, argue that federal prohibition is no longer justified due to widespread state-level legalization and evolving federal enforcement policies. Boies is an expert in constitutional law and is renowned for his role in groundbreaking legal battles, like legal same-sex marriage and the antitrust case against Microsoft.
Boies is contending that the shifts in cannabis regulation and the nation's history of cannabis use, necessitate a reexamination of the federal ban. If he were to win the case, this would immediately impact the status of cannabis at a federal level.
This legal battle coincides with the Biden administration’s ongoing review of cannabis rescheduling, another one of the three paths forward for cannabis legalization.
Cover: AI-generated image
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.